Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Shield Thera Share Price
  4. Shield Thera Share Regulatory News

Pin to quick picksShield Thera Regulatory News (STX)

Shield Thera Information

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.80    0.05 (0.87%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £62.03m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

12345678910
Date   Source Headline
31st Mar 20223:50 pmRNSBlock Listing 6 Monthly Return
21st Mar 20227:00 amRNSKYE Pharmaceuticals Files Accrufer® NDS in Canada
2nd Mar 20221:30 pmEQSHardman & Co Research: Shield Therapeutics (STX) - PBMs have bought in to Accrufer
25th Feb 20227:00 amRNSInvestor Presentation
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
23rd Feb 202211:05 amRNSSecond Price Monitoring Extn
23rd Feb 202211:00 amRNSPrice Monitoring Extension
18th Feb 20222:06 pmRNSSecond Price Monitoring Extn
18th Feb 20222:00 pmRNSPrice Monitoring Extension
17th Feb 20229:05 amRNSSecond Price Monitoring Extn
17th Feb 20229:00 amRNSPrice Monitoring Extension
17th Feb 20227:00 amRNSFull Year Trading Update
4th Feb 20227:00 amRNSKOL Investor Event on Iron Deficiency
7th Jan 20227:00 amRNSInvestor Presentation
5th Jan 20227:00 amRNSLicence Agreement in Canada for Accrufer®
30th Dec 20219:06 amRNSSecond Price Monitoring Extn
30th Dec 20219:00 amRNSPrice Monitoring Extension
29th Dec 202111:05 amRNSSecond Price Monitoring Extn
29th Dec 202111:00 amRNSPrice Monitoring Extension
16th Dec 202111:05 amRNSSecond Price Monitoring Extn
16th Dec 202111:00 amRNSPrice Monitoring Extension
16th Dec 20217:00 amRNSPatient Access Expands for Accrufer®
7th Oct 20219:45 amEQSHardman & Co Research: Shield Therapeutics (STX) Life Sciences Investor Forum research
30th Sep 20215:30 pmRNSBlock Listing 6 Monthly Return
27th Sep 20217:00 amRNSJose A. Menoyo Appointed as Chief Medical Officer
21st Sep 20217:00 amRNSInvestor presentation
23rd Aug 20217:00 amRNSPDMR Transaction Notification
20th Aug 202111:08 amEQSHardman & Co Research: Shield Therapeutics (STX) - Focused on US market penetration
17th Aug 20217:00 amRNSHalf-year Report
12th Aug 20217:25 amEQSHardman & Co Video Event | Shield Therapeutics plc - Investor Forum
12th Aug 20217:00 amRNSLicence agreement secured in Republic of Korea
11th Aug 20217:00 amRNSNotice of Results
9th Aug 20217:00 amRNSAEGIS-CKD study results published in AJKD
4th Aug 20214:41 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20212:05 pmRNSSecond Price Monitoring Extn
4th Aug 20212:00 pmRNSPrice Monitoring Extension
24th Jun 20217:00 amRNSUS launch of Accrufer® confirmed for July 1, 2021
23rd Jun 20214:40 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20211:35 pmRNSInvestor presentation
18th Jun 20217:00 amRNSDirectorate Change
17th Jun 20212:30 pmRNSResults of 2021 Annual General Meeting
15th Jun 20216:15 pmRNSGrant of share options to the CEO
28th May 20217:00 amRNSAppointment of new Chief Executive Officer
28th May 20217:00 amRNSTotal Voting Rights
26th May 202110:35 amEQSHardman & Co Research: Shield Therapeutics (STX): Accrufer launch on schedule
21st May 20217:00 amRNSUS update
18th May 20217:00 amRNSAEGIS-H2H study results published in IBD
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
THR
Thor Energy
LSE
9.09%
BHIB
BHIB.L
LSE
0.00%
DIS
Distil
LSE
48.15%
RC2
RC2.L
LSE
0.00%
VTU
Vertu
LSE
-0.42%
Trending
GGP
Greatland Resources
LSE
-0.42%
RKH
Rockhopper
LSE
1.23%
NANO
Nanoco
LSE
15.54%
AMG
Atlas Metals Group PLC
LSE
2.86%
MPL
Mercantile Ports & Logistics
LSE
3.33%